Apoptosis: A target for anticancer therapy with novel cyanopyridines

Area of Science:

• Medicinal Chemistry
• Cancer Biology
• Pharmacology

Background:

• Targeting the apoptotic pathway is a promising strategy for developing novel anticancer agents.
• Uncontrolled cancer cell proliferation necessitates the discovery of effective chemotherapeutic compounds.

Purpose of the Study:

• To design, synthesize, and evaluate a novel series of cyanopyridine derivatives for antiproliferative activity.
• To investigate the mechanism of action of potent cyanopyridine compounds, including their effects on apoptosis and kinase inhibition.

Main Methods:

• Synthesis of novel cyanopyridine derivatives.
• In vitro antiproliferative assays against various cancer cell lines (PC-3, HepG-2, MCF-7) and a normal cell line (WI-38).
• Mechanistic studies involving caspase-3 activation, BAX/BCL2 ratio analysis, PIM-1 kinase inhibition assays, cell cycle analysis, and in silico ADME profiling.

Main Results:

• Compound 10f exhibited potent inhibition against PC-3 and HepG-2 cells (IC50 = 2.04 µM) with high selectivity (SI = 78.63 and 43).
• Several analogs (10b, 10d, 10f, 10g, 11b) effectively induced apoptosis by increasing active caspase-3 and the BAX/BCL2 ratio (20-95 folds).
• These compounds also demonstrated significant PIM-1 kinase inhibitory activity (IC50 = 0.47-1.27 µM), with 10f inducing G2/M cell cycle arrest and showing favorable in silico ADME properties for oral bioavailability.

Conclusions:

• The novel cyanopyridine derivatives possess significant anticancer potential, acting through apoptosis induction and PIM-1 kinase inhibition.
• Compound 10f is a highly promising lead candidate due to its potent and selective anticancer activity, favorable safety profile, and potential for oral administration.
• These findings support further investigation of cyanopyridines as a new class of anticancer therapeutics.